Markets:

Overview

News

Currencies

International

Treasuries

Merck & Co (NY:MRK)

92.93 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

5 Healthcare Plays Powering the Sector’s Big Comeback ↗

October 09, 2025

After years of lagging, the healthcare sector is showing signs of a turnaround driven by lower rates, policy clarity, and renewed investor interest.

Via MarketBeat

Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025

October 09, 2025

From Merck & Co., Inc.

Via Business Wire

Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025

October 09, 2025

From Merck Sharp & Dohme

Via Business Wire

MERCK INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 08, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Merck, Doctors Reject Proposal To Break Up Combined MMR Vaccine ↗

October 07, 2025

Merck and health experts push back against U.S. officials' call to split the MMR vaccine, warning it could delay immunizations and weaken immune response.

Via Benzinga

How Arcus Biosciences Aims To Take On Merck In Cancer Treatment ↗

October 07, 2025

Shares climbed Tuesday as enthusiasm grows for the biotech company's experimental cancer drug.

Via Investor's Business Daily

Merck Completes Acquisition of Verona Pharma

October 07, 2025

From Merck & Co., Inc.

Via Business Wire

Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases

October 06, 2025

From Merck Sharp & Dohme

Via Business Wire

1 Monster Stock in the Making to Buy and Hold ↗

October 05, 2025

This biotech company was relatively unknown a few years ago.

Via The Motley Fool

Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Markets ↗

October 03, 2025

S&P500, Nasdaq100, Dow Jones, and Russell 2000 all hit record highs as investors focus on corporate optimism, monetary easing and AI tech.

Via Benzinga

Topics Artificial Intelligence Stocks

Merck & Co's Options: A Look at What the Big Money is Thinking ↗

October 03, 2025

Via Benzinga

U.S. Jobs Report Stalled Amidst Federal Shutdown: A Critical Information Vacuum for Markets and Policymakers

October 02, 2025

Washington D.C., October 2, 2025 – As a federal government shutdown extends into its second day, the highly anticipated U.S. Jobs Report, typically released on the first Friday of each month, has been...

Via MarketMinute

Topics Bonds Economy

These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap ↗

October 02, 2025

Health care stocks are rallying, but Pfizer, Merck and Bristol-Myers still trade below 10x forward P/E — a rare market discount.

Via Benzinga

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗

October 02, 2025

Worried about sliding interest on your savings? These three Dow stocks are yielding more than 4%.

Via The Motley Fool

Topics Stocks

Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design

October 02, 2025

London, UK – October 2, 2025 – In a monumental stride for biotechnology and medicine, generative artificial intelligence (AI) has achieved a scientific breakthrough, demonstrating an unprecedented...

Via TokenRing AI

Topics Artificial Intelligence

Nanobiotix Stock Soars on Breakthrough Esophageal Cancer Data, Igniting Biotech Hopes

October 02, 2025

Paris, France – October 2, 2025 – Nanobiotix (NASDAQ: NBTX) witnessed a significant surge in its stock price today, jumping 11.6%, following the announcement of highly encouraging initial data from a...

Via MarketMinute

Wall Street Holds Firm Despite Shutdown and Weak Jobs Data ↗

October 02, 2025

Stocks shrugged off Washington’s chaos as hopes for Fed rate cuts and strong corporate news kept investors in a buying mood.

Via Chartmill

Topics Economy

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years ↗

October 01, 2025

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.

Via Benzinga

Topics Government

Why Merck (MRK) Stock Is Up Today

October 01, 2025

Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 7.7% in the afternoon session after the Trump administration announced a new program to sell drugs directly to consumers.

Via StockStory

Topics Artificial Intelligence Government

Wednesday's session: top gainers and losers in the S&P500 index ↗

October 01, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Via Chartmill

In today's session, there are S&P500 stocks with remarkable trading volume. ↗

October 01, 2025

In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Wednesday's session.

Via Chartmill

Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday? ↗

October 01, 2025

Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat.

Via Benzinga

Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30

October 01, 2025

From Merck & Co., Inc.

Via Business Wire

Global Markets Defy Headwinds: Resilient Sentiment Prevails Despite Shutdown Fears

September 30, 2025

As the third quarter of 2025 drew to a close on September 30, global financial markets demonstrated a remarkable display of resilience, largely shrugging off significant geopolitical uncertainties and...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge

September 30, 2025

Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing...

Via MarketMinute

Topics Economy Government World Trade

What's going on in today's session: S&P500 movers ↗

September 30, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Merck (MRK) Shares Skyrocket, What You Need To Know

September 30, 2025

Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 5.7% in the afternoon session after the company announced positive results from its Phase 3 HYPERION trial for its drug, WINREVAIR™...

Via StockStory

Topics Artificial Intelligence

Tech Revolutionizes Cattle Feeding: A Sustainable Future for Livestock Markets

September 30, 2025

The global cattle feeding industry is at a critical juncture, facing mounting pressures from volatile feed costs, stringent environmental regulations, and a persistent labor crunch. In response, a wave...

Via MarketMinute

Topics Artificial Intelligence Climate Change Emissions

Discover which S&P500 stocks are making waves on Tuesday. ↗

September 30, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Merck & Co (NY:MRK)

All News about Merck & Co

Starting at $3.75/week.

Subscribe Today